In the post-hoc subgroup analysis stratifying the associations by year of ECMO, we found that the associations between immunomodulators and mortality generally increased from 2020 to 2021; nonetheless this did not reach statistical significance.
← all excerpts
Immunomodulators in patients receiving extracorporeal membrane oxygenation for COVID-19: a propensity-score adjusted analysis of the ELSO registry.
1
—
—